Iwanari; Hiroko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Iwanari; Hiroko.The latest application filed is for "cadm1 v9-recognizing antibody".

Company Profile

2.12.14

Iwanari; Hiroko - Tokyo JP
IWANARI; Hiroko - Tochigi JP
Iwanari; Hiroko - Shimotuke N/A JP
IWANARI; HIROKO - SHIMOTUKE-SHI JP
Iwanari; Hiroko - Bunkyo-ku JP
Iwanari; Hiroko - Meguro-ku JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CADM1 V9-Recognizing Antibody App 20210079092 - Murakami; Yoshinori ; et al.	2021-03-18
Method For Killing Tumor Cells And Composition Used Therefor App 20200147233 - HAMAKUBO; Takao ; et al.	2020-05-14
Monoclonal antibody specifically recognizing asparagine synthetase Grant 9,638,697 - Hamakubo , et al. May 2, 2	2017-05-02
Monoclonal antibody, and use thereof Grant 9,155,805 - Hamakubo , et al. October 13, 2	2015-10-13
Monoclonal Antibody Specifically Recognizing Asparagine Synthetase App 20140322726 - Hamakubo; Takao ; et al.	2014-10-30
Therapeutic agents for alzheimer's disease and cancer Grant 8,398,981 - Iwatsubo , et al. March 19, 2	2013-03-19
Therapeutic agents for alzheimer's disease and cancer Grant 8,394,376 - Iwatsubo , et al. March 12, 2	2013-03-12
Diagnostic agent and therapeutic agent for pancreatic cancer Grant 8,273,859 - Aburatani , et al. September 25, 2	2012-09-25
Diagnostic agent and therapeutic agent for pancreatic cancer Grant 8,211,630 - Aburatani , et al. July 3, 2	2012-07-03
Therapeutic Agents For Alzheimer's Disease And Cancer App 20120128694 - IWATSUBO; TAKESHI ; et al.	2012-05-24
Novel Monoclonal Antibody, And Use Thereof App 20120003149 - Hamakubo; Takao ; et al.	2012-01-05
Diagnostic Agent And Therapeutic Agent For Pancreatic Cancer App 20110288278 - Aburatani; Hiroyuki ; et al.	2011-11-24
Therapeutic Agents For Alzheimer's Disease And Cancer App 20110165179 - IWATSUBO; Takeshi ; et al.	2011-07-07
Method of measuring PTX3 with high sensitivity Grant 7,955,807 - Kodama , et al. June 7, 2	2011-06-07
Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody Grant 7,875,705 - Iwanari , et al. January 25, 2	2011-01-25
Diagnostic Agent And Therapeutic Agent For Pancreatic Cancer App 20100316568 - Aburatani; Hiroyuki ; et al.	2010-12-16
Method for predicting and judging the recurrence of liver cancer after treating liver cancer Grant 7,691,586 - Watanabe , et al. April 6, 2	2010-04-06
Method Of Measuring PTX3 With High Sensitivity App 20100062449 - Kodama; Tatsuhiko ; et al.	2010-03-11
Drug For Diagnosing Large Intestinal Cancer And/or Polyp, Observing Postoperative Course And Monitoring Recurrence App 20100041167 - Aburatani; Hiroyuki ; et al.	2010-02-18
Therapeutic Agents For Alzheimer's Disease And Cancer App 20090220524 - Iwatsubo; Takeshi ; et al.	2009-09-03
Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody App 20090092544 - Iwanari; Hiroko ; et al.	2009-04-09
Agent for Predicting and Judging the Recurrence After Treating Liver Cancer App 20080138827 - Watanabe; Kiyotaka ; et al.	2008-06-12
Monitoring Agent for Seriousness of Hepatitis App 20080003623 - Nakajima; Atsushi ; et al.	2008-01-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.